Israeli scientists found a way to treat deadly pancreatic cancer in just 14 days

A new treatment developed by Tel Aviv University can destroy pancreatic cancer cells, destroying 90% of cancer cells after 2 weeks of injecting a small amount of molecule called PJ34.

Pancreatic cancer is one of the most difficult cancers to treat. Most people diagnosed with the disease only live about five years after being diagnosed, far less than many other forms of cancer.

Professor Malka Cohen-Armon and Dr. Talia Golan.

The research was led by Professor Malka Cohen-Armon and her team in collaboration with Dr. Talia Golan, at the Cancer Research Center, Sheba Medical Center.

Specifically, research shows that a small molecule called PJ34 is injected into a vein that causes the self-destruction of cancer cells in humans.

The study was conducted by implanting human pancreatic cancer into immunocompromised mice. One month after injecting this molecule daily for 14 days, there was a 90% reduction in pancreatic cells in the tumor. A rat with a tumor disappeared completely.

This molecule causes abnormalities in the mitosis process of human cancer cells, causing rapid cell death.

Furthermore, Malka Cohen-Armon said, PJ34 does not seem to have an impact on healthy cells, so no side effects were observed. The mice, she said continue to grow and gain weight as usual.

Although Cohen-Armon said the team did not specifically study whether treatment could extend a patient's life span, at least it was a remarkable option because cancer cells could be removed. letter.

With the question of how long will it take to switch from mouse testing to human testing? Malka Cohen-Armon said that it was estimated at least two years on the condition that there was sufficient funding and other issues.

In the near future, Malka Cohen-Armon said the team will test the treatment in pigs and then ask for FDA approval when considering human trials.